Lpl Financial LLC Cogent Biosciences, Inc. Transaction History

Lpl Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$10.65 - $14.84 $15,975 - $22,260	-1,500 Reduced 9.22%	14,774 $170,000
Q3 2022 Nov 14, 2022	BUY	$9.39 - $16.99 $152,812 - $276,495	16,274 New	16,274 $243,000
Q3 2021 Nov 15, 2021	SELL	$5.99 - $9.14 $89,850 - $137,100	-15,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$7.82 - $9.3 $31,280 - $37,200	4,000 Added 36.36%	15,000 $122,000
Q1 2021 May 14, 2021	BUY	$7.47 - $12.34 $82,170 - $135,740	11,000 New	11,000 $97,000

172

114M

56.7K

40.4K

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $528M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.